Patent ID: 9701747
Date: 2017-07-11
CPC Classifications: A61K,C07K,G01N

Claim:
1. A therapeutic regimen for improving survivability or quality of life of a patient in need thereof having elevated C-reactive protein levels, and decreased serum albumin levels, comprising administering a first composition which comprises an amount of an anti-interleukin-6 (“IL-6”), antibody or anti-IL-6 antibody fragment effective to reduce CRP levels and/or increase serum albumin levels, wherein the antibody or antibody fragment has the variable light (V L ) polypeptide of SEQ ID NO:20 and the V H polypeptide of SEQ ID NO:19, and further comprising administering a second active agent other than said anti-IL-6 antibody or anti-IL-6 antibody fragment which second active agent is comprised in the first composition or is comprised in a second composition.